Verastem, Inc. · NASDAQ:VSTM
BVF PARTNERS L P/IL reported a 9.99% stake in Verastem, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 13, 2025
BVF PARTNERS L P/IL reported a 9.99% stake in Verastem, Inc., 5,720,831 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 5,720,831
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.80% | 3,244,310 |
| BVF I GP LLC | 5.80% | 3,244,310 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.90% | 2,173,798 |
| BVF II GP LLC | 3.90% | 2,173,798 |
| Biotechnology Value Trading Fund OS LP | 0.40% | 214,663 |
| BVF Partners OS Ltd. | 0.40% | 214,663 |
| BVF GP HOLDINGS LLC | 9.50% | 5,418,108 |
| BVF PARTNERS L P/IL | 9.99% | 5,720,831 |
| BVF INC/IL | 9.99% | 5,720,831 |
| LAMPERT MARK N | 9.99% | 5,720,831 |
Source
Related
- Verastem, Inc.
- Biotechnology Value Fund L P
- Verastem, Inc. shareholders
- Schedule 13G/A · Biotechnology Value Fund L P · Aug 13, 2025
- Schedule 13G/A · Biotechnology Value Fund L P · Feb 14, 2025
- Form 4 · Calkins Daniel · Oct 2, 2026
- Form 4 · Paterson Dan · Oct 2, 2026
- Form 4 · Calkins Daniel · Sep 23, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026